Nitric oxide-releasing polymers containing the [N(O)NO](-) group

被引:182
作者
Smith, DJ
Chakravarthy, D
Pulfer, S
Simmons, ML
Hrabie, JA
Citro, ML
Saavedra, JE
Davies, KM
Hutsell, TC
Mooradian, DL
Hanson, SR
Keefer, LK
机构
[1] SAIC,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD
[2] NCI,FREDERICK CANC RES & DEV CTR,COMPARAT CARCINOGENESIS LAB,CHEM SECT,FREDERICK,MD 21702
[3] GEORGE MASON UNIV,DEPT CHEM,FAIRFAX,VA 22030
[4] COMEDICUS INC,COLUMBIA HEIGHTS,MN 55421
[5] UNIV MINNESOTA,DEPT LAB MED & PATHOL,CTR BIOMED ENGN,MINNEAPOLIS,MN 55455
[6] EMORY UNIV,YERKES REG PRIMATE RES CTR,ATLANTA,GA 30322
[7] EMORY UNIV,DIV HEMATOL,ATLANTA,GA 30322
关键词
D O I
10.1021/jm950652b
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ions of structure X[N(O)NO](-) display broad-spectrum pharmacological activity that correlates with the rate and extent of their spontaneous, first-order decomposition to nitric oxide when dissolved. We report incorporation of this functional group into polymeric matrices that can be used for altering the time course of nitric oxide release and/or targeting it to tissues with which the polymers are in physical contact. Structural types prepared include those in which the [N(O)NO]- group is attached to heteroatoms in low molecular weight species that are noncovalently distributed throughout the polymeric matrix, in groupings pendant to the polymer backbone, and in the polymer backbone itself. They range in physical form from films that can be coated onto other surfaces to microspheres, gels, powders, and moldable resins. Chemiluminescence measurements confirm that polymers to which the [N(O)NO](-) group is attached can serve as localized sources of nitric oxide, with one prototype providing sustained NO release for 5 weeks in pH 7.4 buffer at 37 degrees C. The latter composition, a cross-linked poly(ethylenimine) that had been exposed to NO, inhibited the in vitro proliferation of rat aorta smooth muscle cells when added as a powder to the culture medium and showed potent antiplatelet activity when coated on a normally thrombogenic vascular graft situated in an arteriovenous shunt in a baboon's circulatory system. The results suggest that polymers containing the [N(O)NO]- functional group may hold considerable promise for a variety of biomedical applications in which local delivery of NO is desired.
引用
收藏
页码:1148 / 1156
页数:9
相关论文
共 39 条
[1]  
Bearn P E, 1994, J R Coll Surg Edinb, V39, P1
[2]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[3]  
DIODATI JG, 1993, THROMB HAEMOSTASIS, V70, P654
[4]   COMPLEXES OF NITRIC-OXIDE WITH NUCLEOPHILES AS AGENTS FOR THE CONTROLLED BIOLOGICAL RELEASE OF NITRIC-OXIDE - HEMODYNAMIC-EFFECT IN THE RABBIT [J].
DIODATI, JG ;
QUYYUMI, AA ;
KEEFER, LK .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (02) :287-292
[5]   THE REACTION OF NITROGEN(II) OXIDE WITH DIETHYLAMINE [J].
DRAGO, RS ;
PAULIK, FE .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1960, 82 (01) :96-98
[6]   REACTION OF NITROGEN(II) OXIDE WITH VARIOUS PRIMARY AND SECONDARY AMINES [J].
DRAGO, RS ;
KARSTETTER, BR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1961, 83 (08) :1819-+
[7]  
DRAGO RS, 1962, ADV CHEM SER, V36, P143
[8]   NITRIC OXIDE-GENERATING VASODILATORS AND 8-BROMO-CYCLIC GUANOSINE-MONOPHOSPHATE INHIBIT MITOGENESIS AND PROLIFERATION OF CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
GARG, UC ;
HASSID, A .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) :1774-1777
[9]   EXOGENOUS NITRIC-OXIDE INHIBITS INVIVO PLATELET-ADHESION FOLLOWING BALLOON ANGIOPLASTY [J].
GROVES, PH ;
PENNY, WJ ;
CHEADLE, HA ;
LEWIS, MJ .
CARDIOVASCULAR RESEARCH, 1992, 26 (06) :615-619
[10]   BENEFICIAL EFFECT OF SPM-5185, A CYSTEINE-CONTAINING NITRIC-OXIDE DONOR, IN RAT CAROTID-ARTERY INTIMAL INJURY [J].
GUO, JP ;
MILHOAN, KA ;
TUAN, RS ;
LEFER, AM .
CIRCULATION RESEARCH, 1994, 75 (01) :77-84